Daniel Thut

Daniel Thut is a Senior Market Access Portfolio Manager at AstraZeneca, leading a team focused on delivering reimbursed access for key portfolios in Australia. They have extensive experience in market access, public affairs, and medical affairs across various companies, including Novo Nordisk and Bayer. Daniel holds a MSc in Developmental and Cell Biology from the University of Fribourg and a BSc in Science from Victoria University of Wellington. Known for their authentic leadership style, they prioritize trust and respect within their teams while maintaining a deep understanding of the Australian payer and pharmaceutical environment.